Lancet Oncol: Can cancer patients get the new crown vaccine?

At present, China is vigorously promoting the new crown pneumonia vaccination, not only free of charge, but even some areas have begun to vaccinate to send edible oil or Starbucks coffee (choose one).

Can patients with new coronary pneumonia cancer be vaccinated against new coronary pneumonia? Can cancer patients be vaccinated against new coronary pneumonia vaccine?

There are no clear data on the effectiveness and safety of the new coronary pneumonia vaccine in cancer patients.

The Lancet Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study COVID-19 immunity

The study is a prospective observational study.

A total of 151 cancer patients (95 solid tumors, 56 hematological tumors) and 54 healthy controls were recruited.

Immunogenicity of BNT162b2 vaccine

Immunogenicity of BNT162b2 vaccine

Sixteen healthy controls, 25 patients with solid tumors, and 6 patients with hematological tumors received the second dose of vaccine on day 21.

100% of healthy controls (12/12), 95% of patients with solid tumors (18/19), and 60% (3/5) of patients with hematological tumors have positive sera

Serological response of BNT162b2 vaccine

Serological response of BNT162b2 vaccine

The vaccine is well tolerated .

The vaccine is well tolerated.

For cancer patients, a dose of BNT162b2 vaccine is not effective.

Original source:

Leticia Monin, et al.

org/10.
1016/S1470-2045(21)00213-8" target="_blank" rel="noopener">Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study in this message